PetIQ Inc

PetIQ Inc(PETQ)股票分析

$30.990

0.000 (0.00%)收盘时

Loading chart…
最高
30.990
开盘
30.990
成交量加权均价
—
成交量
0.00
市值
654.17M
最低
30.990
成交额
0.00
企业价值/息税折旧摊销前利润(TTM)
10.35

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels. The Company has two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to the retail and e-commerce channels. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. It offers and supplies these products to customers primarily in the United States. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 41 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks.

petiq.com

分析师评级(5)

买入
4 买入
1 持有
0 卖出
当前: 30.99
最低
—
平均
—
最高
—

Truist Securities

2024-08-08

目标价

$31

持有

Benchmark

2024-05-10

目标价

$30

强烈买入

Jefferies

2024-03-19

目标价

$28

强烈买入

Jefferies

2023-12-19

目标价

$22

强烈买入

Truist Securities

2023-10-02

目标价

$30

强烈买入

估值指标

PetIQ Inc(PETQ)当前预期市盈率为 17.77,5 年平均预期市盈率为 15.03。

预期市盈率

合理
5 年均值 P/E
15.03
当前P/E
17.77
高估
19.33
低估
10.74

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
9.01
当前EV/EBITDA
10.35
高估
10.44
低估
7.57

预期市销率

高估
5 年均值 P/S
0.49
当前P/S
0.75
高估
0.63
低估
0.34

PETQ 常见问题 —— 由 Alphio AI 解答

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels. The Company has two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to the retail and e-commerce channels. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. It offers and supplies these products to customers primarily in the United States. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 41 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).

5 analysts cover PETQ: 4 rate it Buy, 1 Hold and 0 Sell.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易